טוען...
Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure
BACKGROUND: For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfortunately, survival is still poor due to distant metastases, which remains the leading cause of...
שמור ב:
| הוצא לאור ב: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7896420/ https://ncbi.nlm.nih.gov/pubmed/33643528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v13.i2.119 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|